Sign in

CIK 0001549595

  • Large accelerated filer

Nurix Therapeutics, Inc.

Sign in to watch
Ticker
NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Nov 30
Incorporated
DE
Entity type
Operating
EIN
270838048
Phone
+1 415-660-5320
Business address
1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
Former names
Nurix, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market sale EVP and COO sold 342 shares at $9.88 ($3,378)
  5. 4 Open-market sale Chief Financial Officer sold 721 shares at $9.88 ($7,121)
  6. 4 Open-market sale General Counsel sold 682 shares at $9.88 ($6,736)
  7. 4 Open-market sale Chief Scientific Officer sold 1,136 shares at $9.88 ($11,219)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market sale EVP and COO sold 424 shares at $11.78 ($4,995)
  14. 4 Open-market sale Chief Financial Officer sold 924 shares at $11.78 ($10,884)
  15. 4 Open-market sale General Counsel sold 848 shares at $11.78 ($9,989)
  16. 4 Open-market sale Chief Scientific Officer sold 1,412 shares at $11.78 ($16,633)
  17. 4 Open-market sale Chief Financial Officer sold 739 shares at $12.88 ($9,519)
  18. 4 Open-market sale General Counsel sold 699 shares at $12.88 ($9,003)
  19. 4 Open-market sale Chief Scientific Officer sold 1,165 shares at $12.88 ($15,006)
  20. 4 Open-market sale EVP and COO sold 350 shares at $12.88 ($4,508)

Page 8 of 14 · 274 filings